ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,752Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 680

$1.19M Total Retail Price of All Prescriptions

Rank: 48 out of 680

799 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 799 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

19% of this provider’s 799 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 22,663 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 1,468 1,375 1 2
AMLODIPINE BESYLATE 709 666 2 1
OMEPRAZOLE 707 636 3 7
METFORMIN HCL 668 579 4 8
MELOXICAM 619 530 5 24
FUROSEMIDE 619 538 5 6
HYDROCODONE-ACETAMINOPHEN 562 469 S3 7 4
CITALOPRAM HBR 510 436 8 22
SIMVASTATIN 444 383 9 3
BENAZEPRIL HCL 436 395 10 40
LEVOFLOXACIN 417 361 11 97
GABAPENTIN 404 341 12 15
PRAVASTATIN SODIUM 357 300 13 10
POTASSIUM CHLORIDE 343 312 14 14
CLOPIDOGREL 332 316 15 26
ZOLPIDEM TARTRATE 330 271 16 17
NEXIUM 327 277 17 16
HYDROCHLOROTHIAZIDE 317 301 18 9
ATORVASTATIN CALCIUM 305 262 19 11
LISINOPRIL 302 268 20 5
METOPROLOL SUCCINATE 298 259 21 13
GLIMEPIRIDE 289 265 22 29
SERTRALINE HCL 285 229 23 28
SYNTHROID 279 270 24 38
LOSARTAN POTASSIUM 255 225 25 21
TRAMADOL HCL 255 202 25 18
DONEPEZIL HCL 250 227 27 27
QUINAPRIL HCL 249 206 28 104
PLAVIX 233 228 29 39
HYDRALAZINE HCL 229 206 30 71
FLUTICASONE PROPIONATE 222 183 31 41
PREDNISONE 218 181 32 50
AMLODIPINE BESYLATE-BENAZEPRIL 214 157 33 43
GEMFIBROZIL 213 207 34 106
CYMBALTA 203 157 35 46
METOPROLOL TARTRATE 202 182 36 12
CARVEDILOL 198 180 37 23
LOSARTAN-HYDROCHLOROTHIAZIDE 191 159 38 51
WARFARIN SODIUM 186 177 39 20
DIOVAN 176 167 40 31
FLUOXETINE HCL 170 136 41 74
CLONIDINE HCL 167 151 42 36
CRESTOR 158 153 43 25
LOVASTATIN 145 145 44 44
DEXILANT 144 131 45 171
TRAZODONE HCL 140 116 46 48
NAMENDA 139 139 47 35
ALLOPURINOL 139 127 47 33
ISOSORBIDE MONONITRATE ER 135 115 49 59
DICLOFENAC SODIUM 132 106 50 162
DILTIAZEM 24HR ER 128 128 51 132
LISINOPRIL-HYDROCHLOROTHIAZIDE 127 112 52 37
LYRICA 127 102 52 77
CYCLOBENZAPRINE HCL 125 95 R 54 81
PREMARIN 124 109 R 55 105
DIOVAN HCT 123 111 56 55
DIGOXIN 122 107 57 58
LIPITOR 121 116 58 68
LANTUS 121 96 58 49
PANTOPRAZOLE SODIUM 117 113 60 30
FENOFIBRATE 115 97 61 66
BENICAR 114 114 62 131
TRIAMTERENE-HCTZ 114 108 62 52
TORSEMIDE 113 104 64 163
TAMSULOSIN HCL 112 80 65 34
POLYETHYLENE GLYCOL 3350 108 108 66 62
TIZANIDINE HCL 102 82 67 140
ALPRAZOLAM 97 74 68 72
LABETALOL HCL 96 91 69 158
MEGESTROL ACETATE 94 90 R 70 88
ADVAIR DISKUS 94 88 70 53
TRICOR 93 53 72 98
CEFDINIR 92 77 73 212
PROAIR HFA 92 67 73 67
GLIPIZIDE 85 75 75 63
ESCITALOPRAM OXALATE 82 75 76 45
AZOR 82 67 76 278
AMITRIPTYLINE HCL 82 63 R 76 47
CIPROFLOXACIN HCL 79 66 79 57
SINGULAIR 78 58 80 91
ATENOLOL 77 72 81 19
PRISTIQ ER 77 53 81 241
RAMIPRIL 73 73 83 69
MECLIZINE HCL 72 71 84 103
GLIPIZIDE XL 71 71 85 142
CARBIDOPA-LEVODOPA 71 69 85 117
BENICAR HCT 71 50 85 150
ROPINIROLE HCL 69 59 88 99
OXYBUTYNIN CHLORIDE ER 68 68 89 143
VYTORIN 67 59 90 152
DOXYCYCLINE HYCLATE 67 54 90 95
ZETIA 67 62 90 87
FLUCONAZOLE 66 55 93 139
SPIRIVA 64 63 94 70
METHYLPREDNISOLONE 63 52 95 93
ALENDRONATE SODIUM 60 60 96 32
NYSTATIN-TRIAMCINOLONE 59 55 97 310
MONTELUKAST SODIUM 59 41 97 157
ESTROPIPATE 58 50 R 99 381
CLINDAMYCIN HCL 58 52 99 243
AZITHROMYCIN 58 54 99 42
MICARDIS 57 57 102 300
TOPIRAMATE 56 50 103 233
DETROL LA 56 56 103 169
NAPROXEN 56 47 103 121
RISPERIDONE 55 52 106 80
EXELON 55 54 106 112
SUCRALFATE 53 45 108 160
IBUPROFEN 52 31 109 126
SOTALOL 51 51 110 226
INSULIN SYRINGE 51 51 110 86
SPIRONOLACTONE 51 47 110 82
VERAPAMIL ER 50 46 113 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 24, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.